Christopher Paul Simms Net Worth

The estimated Net Worth of Christopher Paul Simms is at least $2.06 Million dollars as of 2 January 2023. Mr Simms owns over 6,250 units of IVERIC bio Inc stock worth over $1,390,140 and over the last 3 years he sold ISEE stock worth over $0. In addition, he makes $668,251 as Sr. VP & Chief Commercial Officer at IVERIC bio Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Simms ISEE stock SEC Form 4 insiders trading

Mr has made over 3 trades of the IVERIC bio Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 6,250 units of ISEE stock worth $249,688 on 2 January 2023.

The largest trade he's ever made was exercising 33,750 units of IVERIC bio Inc stock on 2 August 2022 worth over $1,348,313. On average, Mr trades about 7,178 units every 68 days since 2021. As of 2 January 2023 he still owns at least 34,797 units of IVERIC bio Inc stock.

You can see the complete history of Mr Simms stock trades at the bottom of the page.

Mr. Christopher Paul Simms biography

Christopher Paul Simms is the Sr. VP & Chief Commercial Officer at IVERIC bio Inc.

What is the salary of Mr Simms?

As the Sr. VP & Chief Commercial Officer of IVERIC bio Inc, the total compensation of Mr Simms at IVERIC bio Inc is $668,251. There are 8 executives at IVERIC bio Inc getting paid more, with Glenn Sblendorio having the highest compensation of $2,462,150.

How old is Mr Simms?

Mr Simms is 46, he's been the Sr. VP & Chief Commercial Officer of IVERIC bio Inc since . There are 12 older and 1 younger executives at IVERIC bio Inc. The oldest executive at IVERIC bio Inc is Calvin Roberts, 67, who is the Independent Director.

What's Mr Simms's mailing address?

Christopher's mailing address filed with the SEC is C/O IVERIC BIO, INC., 8 SYLVAN WAY, PARSIPPANY, NJ, 07054.

Insiders trading at IVERIC bio Inc

Over the last 6 years, insiders at IVERIC bio Inc have traded over $8,677,595 worth of IVERIC bio Inc stock and bought 130,569 units worth $624,325 . The most active insiders traders include Glenn Sblendorio, Venture Capital Iv, L.P.Ver... und Keith Westby. On average, IVERIC bio Inc executives and independent directors trade stock every 15 days with the average trade being worth of $848,338. The most recent stock trade was executed by Keith Westby on 3 July 2023, trading 20,000 units of ISEE stock currently worth $58,800.

What does IVERIC bio Inc do?

we are a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye, with a focus on developing therapeutics for age-related macular degeneration (amd).

Complete history of Mr Simms stock trades at IVERIC bio Inc

IVERIC bio Inc executives and stock owners

IVERIC bio Inc executives and other stock owners filed with the SEC include:

• Glenn Sblendorio,
  President, Chief Executive Officer, Director
• David Guyer,
  Executive Chairman of the Board
• Anthony S. Gibney,
  Exec. VP and Chief Bus. & Strategy Officer
• David Carroll,
  Chief Financial Officer, Senior Vice President, Treasurer
• Keith Westby,
  Chief Operating Officer, Senior Vice President
• Glenn P. Sblendorio M.B.A.,
  CEO & Director
• Dr. Pravin U. Dugel M.D.,
  Pres
• David F. Carroll M.B.A.,
  Sr. VP, CFO & Treasurer
• Christopher Paul Simms,
  Sr. VP & Chief Commercial Officer
• David F. Carroll,
  Sr. VP, CFO & Treasurer
• Keith Westby M.B.A.,
  Sr. VP & COO
• Calvin Roberts,
  Independent Director
• Jane Henderson,
  Independent Director
• Adrienne Graves,
  Lead Independent Director
• Axel Bolte,
  Independent Director
• Kathy Galante,
  Vice President, Investor Relations and Corporate Communications
• Mark Blumenkranz,
  Director
• Abraham Scaria,
  Chief Scientific Officer
• Evelyn Harrison,
  Sr. VP & Chief Clinical Operations Officer
• Amy R. Sheehan,
  Sr. VP & Chief HR Officer
• Todd D.C. Anderman,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Dr. Xiao-Ping Dai Ph.D.,
  Chief Technical Officer
• Dr. Samir C. Patel,
  Co-Founder and Consultant
• Christopher Paul Simms,
  SVP, Chief Commercial Officer
• Christine Ann Miller,
  Director
• David E Redlick,
  Director
• Venture Capital Iv, L.P.Ver...,
  
• Anthony S Gibney,
  EVP, Chief Business Officer
• Pravin Dugel,
  President